Vaccine value profile for norovirus
Year: 2023
Type: article
Abstract: Norovirus is attributed to nearly 1 out of every 5 episodes of diarrheal disease globally and is estimated to cause approximately 200,000 deaths annually worldwide, with 70,000 or more among children in developing countries. Noroviruses remain a leading cause of sporadic disease and outbreaks of acute gastroenteritis even in industrialized settings, highlighting that improved hygiene and sanitation alone may not be fully effective in controlling norovirus. Strengths in global progress towards a Norovirus vaccine include a diverse though not deep pipeline which includes multiple approaches, including some with proven technology platforms (e.g., VLP-based HPV vaccines). However, several gaps in knowledge persist, including a fulsome mechanistic understanding of how the virus attaches to human host cells, internalizes, and induces disease.
Source: Vaccine
Authors: George Armah, Ben A. Lopman, Jan Vinjé, Miguel O'Ryan, Claudio F. Lanata, Michelle Groome, Jared Ovitt, Caroline Marshall, Elizabeth Sajewski, Mark S. Riddle
Institutions: University of Ghana, Noguchi Memorial Institute for Medical Research, Emory University, Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases, Complex Engineering System Institute, University of Chile, Instituto de Investigación Nutricional, National Health Laboratory Service, University of the Witwatersrand, National Institute for Communicable Diseases, University of Nevada, Reno, World Health Organization
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,350
OpenAlex ID: W4387410098
